RxDoctor Payments Data

C Mark Rose, DO

Family Medicine · Richmond, MONPI 1265408215

Payments from drug & device makers

$12,931in general payments, 2019–2025

Across 913 payments — averaging $14.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$1K
  • Teva Pharmaceuticals USA, Inc.$970
  • Pfizer$879
  • Abbott$850
  • AstraZeneca$825
  • plus $6K from 52 others

What the payments were for

  • Food & beverage$12,85199%
  • Education$801%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)166$2,024
Lilly USA, LLC87$1,195
Teva Pharmaceuticals USA, Inc.64$970
Pfizer75$879
Abbott37$850
AstraZeneca47$825
Merck33$487
Novo Nordisk32$434
Sunovion Pharmaceuticals Inc.48$371
Boehringer Ingelheim28$331
Vanda Pharmaceuticals Inc.13$327
Otsuka America Pharmaceutical, Inc.17$321
Amgen(2 entities)21$316
Sumitomo Pharma America, Inc.28$302
Mylan Specialty L.p.18$288
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC24$262
Novartis18$253
Astellas Pharma US Inc11$251
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)14$205
Dexcom, Inc.8$186
Antares Pharma, Inc.11$171
Johnson & Johnson12$157
Sanofi-aventis U.S. LLC10$136
Philips North America LLC13$128
E.r. Squibb & Sons, L.L.C.8$110
Exact Sciences6$104
Biohaven Pharmaceutical Holding Company Ltd.6$103
Takeda Pharmaceuticals U.S.A., Inc.6$93
Eisai Inc.4$71
Optinose US, Inc.3$63
Viatris Specialty LLC3$57
Supernus Pharmaceuticals, Inc.3$51
GSK4$49
Covis Pharma GmbH3$49
Biohaven Pharmaceuticals, Inc.3$42
MDD US Operations, LLC2$38
Amarin Pharma, Inc.3$37
Phathom Pharmaceuticals, Inc.2$34
Bayer2$29
Idorsia Pharmaceuticals US Inc2$27
Tactile Systems Technology Inc1$24
Hologic Sales And Service, LLC1$23
Grifols USA, LLC1$23
Neurocrine Biosciences, Inc.1$22
Scilex Pharmaceuticals Inc.1$20
Baxter Healthcare1$19
Vertex1$17
Evoke Pharma, Inc.1$16
Redhill Biopharma Inc.1$16
Lupin Inc.1$15
Axsome Therapeutics, Inc.1$15
Genentech USA, Inc.1$15
Daiichi Sankyo Inc.1$14
Halozyme Inc1$14
Kowa Pharmaceuticals America, Inc.1$14
Collegium Pharmaceutical, Inc.1$13
Esperion Therapeutics, Inc.1$13
Vertical Pharmaceuticals, LLC1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,931 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$4,275
Medicare patients
63
Services billed
212

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide270$286,133
EliquisApixaban226$159,227
JardianceEmpagliflozin161$130,339
MounjaroTirzepatide73$86,613
JanuviaSitagliptin Phosphate92$78,343
XareltoRivaroxaban80$63,753
Trelegy ElliptaFluticasone/Umeclidin/Vilanter69$63,373
VraylarCariprazine Hcl29$44,630
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr77$44,030
TrulicityDulaglutide41$39,239
FarxigaDapagliflozin Propanediol42$33,724
MyrbetriqMirabegron45$25,915
GemtesaVibegron31$23,550
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen575$20,752
LinzessLinaclotide28$19,630

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$434$286,133270 claims
Boehringer IngelheimJardiance, Combivent Respimat, Tradjenta, Stiolto Respimat$331$161,469222 claims
PfizerEliquis$879$159,227226 claims
Lilly USA, LLCMounjaro, Trulicity$1,195$125,852114 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$49$115,040166 claims
MerckJanuvia, Janumet Xr$487$96,481114 claims
AbbVieVraylar, Linzess$2,024$64,26057 claims
Johnson & JohnsonXarelto$157$63,75380 claims
AstraZenecaFarxiga, Breztri Aerosphere$825$45,36258 claims
Astellas Pharma US IncMyrbetriq$251$25,91545 claims
Sumitomo Pharma America, Inc.Gemtesa$302$23,55031 claims
NovartisEntresto$253$10,91216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Richmond

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →